A psychoneuroimmunological review on cytokines involved in antidepressant treatment response-Reference-Cited by-同舟云学术

A psychoneuroimmunological review on cytokines involved in antidepressant treatment response

Published:2010-04 Issue:3 Volume:25 Page:201-215
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol. Clin. Exp.

Author:

Janssen Debbie G. A.,Caniato Riccardo N.,Verster Joris C.,Baune Bernhard T.

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology

Reference108 articles.

1. Lifetime risk of depression: restricted to a minority or waiting for most?;Andrews;Br J Psychiatry,2005

2. Interleukin-1 beta production in dysthymia before and after pharmacotherapy;Anisman;Biol Psychiatry,1999

3. IL-6 levels decrease with SSRI treatment in patients with major depression;Basterzi;Hum Psychopharmacol,2005

4. The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression;Baune;Biol Psychiatry

5. A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice;Brustolim;Int Immunopharmacol,2006

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The neurodegenerative hypothesis of depression and the influence of antidepressant medications;European Journal of Pharmacology;2024-11

2. A concise review of pharmacological and nonpharmacologic therapeutics in psychodermatology;Journal of the Egyptian Women's Dermatologic Society;2024-08-30

3. Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets;Psychopharmacology;2024-05-27

4. Duloxetine protected indomethacin-induced gastric mucosal injury by increasing serotonin-dependent RANTES expression and activating PI3K-AKT-VEGF pathway;Toxicology and Applied Pharmacology;2024-05

5. tiRNA‐Gly‐GCC‐001 in major depressive disorder: Promising diagnostic and therapeutic biomarker;British Journal of Pharmacology;2024-03-04